The rise of injectables for medical and aesthetic use requires improved safety measures. Scarletred®Vision's imaging technology improves patient care and research by setting a new standard for injectable safety and efficacy.

Chronic spontaneous urticaria poses challenges such as long term treatment options. Innovations like Scarletred®Vision aid monitoring and research, offering real-time data and tissue classification for personalized treatment.